Literature DB >> 10379871

A recurring pattern of chromosomal aberrations in mammary gland tumors of MMTV-cmyc transgenic mice.

Z A Weaver1, S J McCormack, M Liyanage, S du Manoir, A Coleman, E Schröck, R B Dickson, T Ried.   

Abstract

Mice carrying the MMTV-cmyc transgene develop mammary tumors at 9 to 12 months of age. Little is known about karyotypic changes in this model of human breast cancer. We have developed and applied molecular cytogenetic techniques to study chromosomal aberrations that occur in these tumors, namely, comparative genomic hybridization and spectral karyotyping. Cell lines from eight tumors were established and analyzed, four of which carried a heterozygous p53 mutation. All of the tumor cell lines revealed increases in ploidy and/or multiple numerical and structural chromosomal aberrations. No consistent differences were observed between cmyc/p53+/+ and cmyc/p53+/- tumors, suggesting that cmyc induces karyotype instability independent of p53 status. Loss of whole chromosome (Chr) 4 was detected in five of the eight tumors. Parts of Chr 4 are syntenic to human 1p31-p36, a region that is also deleted in human breast carcinomas. Four tumors carried translocations involving the distal portion of Chr 11 (syntenic to human chromosome arm 17q), including two translocations T(X;11), with cytogenetically identical breakpoints. We compare the pattern of chromosomal aberrations with human breast cancers, find similarities in several syntenic regions, and discuss the potential of an interspecies cytogenetic map of chromosomal gains and losses.

Entities:  

Mesh:

Year:  1999        PMID: 10379871

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  28 in total

1.  Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells.

Authors:  Jason I Herschkowitz; Wei Zhao; Mei Zhang; Jerry Usary; George Murrow; David Edwards; Jana Knezevic; Stephanie B Greene; David Darr; Melissa A Troester; Susan G Hilsenbeck; Daniel Medina; Charles M Perou; Jeffrey M Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-01       Impact factor: 11.205

2.  Molecular cytogenetics of mouse models of breast cancer.

Authors:  Thomas Ried; Kathy Dorritie; Zoë Weaver; Danny Wangsa; Michael J Difilippantonio; Cristina Montagna
Journal:  Breast Dis       Date:  2004

Review 3.  Of mice and Myc: c-Myc and mammary tumorigenesis.

Authors:  M Hunter Jamerson; Michael D Johnson; Robert B Dickson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

Review 4.  Genomic analyses as a guide to target identification and preclinical testing of mouse models of breast cancer.

Authors:  Christina N Bennett; Jeffrey E Green
Journal:  Toxicol Pathol       Date:  2010-01-15       Impact factor: 1.902

5.  Aneuploidy, oncogene amplification and epithelial to mesenchymal transition define spontaneous transformation of murine epithelial cells.

Authors:  Hesed M Padilla-Nash; Nicole E McNeil; Ming Yi; Quang-Tri Nguyen; Yue Hu; Danny Wangsa; David L Mack; Amanda B Hummon; Chanelle Case; Eric Cardin; Robert Stephens; Michael J Difilippantonio; Thomas Ried
Journal:  Carcinogenesis       Date:  2013-04-25       Impact factor: 4.944

6.  H2AX haploinsufficiency modifies genomic stability and tumor susceptibility.

Authors:  Arkady Celeste; Simone Difilippantonio; Michael J Difilippantonio; Oscar Fernandez-Capetillo; Duane R Pilch; Olga A Sedelnikova; Michael Eckhaus; Thomas Ried; William M Bonner; André Nussenzweig
Journal:  Cell       Date:  2003-08-08       Impact factor: 41.582

Review 7.  Common integration sites for MMTV in viral induced mouse mammary tumors.

Authors:  Robert Callahan; Gilbert H Smith
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-08-15       Impact factor: 2.673

8.  Mammary tumorigenesis following transgenic expression of a dominant negative CHK2 mutant.

Authors:  Eunice L Kwak; Sang Kim; Jianmin Zhang; Robert D Cardiff; Emmett V Schmidt; Daniel A Haber
Journal:  Cancer Res       Date:  2006-02-15       Impact factor: 12.701

9.  Aberrant V(D)J recombination is not required for rapid development of H2ax/p53-deficient thymic lymphomas with clonal translocations.

Authors:  Craig H Bassing; Sheila Ranganath; Mike Murphy; Velibor Savic; Meagan Gleason; Frederick W Alt
Journal:  Blood       Date:  2007-09-13       Impact factor: 22.113

Review 10.  Unlocking the power of cross-species genomic analyses: identification of evolutionarily conserved breast cancer networks and validation of preclinical models.

Authors:  Christina N Bennett; Jeffrey E Green
Journal:  Breast Cancer Res       Date:  2008-09-11       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.